Entecavir results in continued virologic and biochemical improvement and HBeAg seroconversion through 96 weeks of treatment in lamivudine-refractory, HBeAg(+) chronic hepatitis B patients (ETV-026)


Yurdaydin C., Sollano J., Hadziyannis S., Kaymakoglu S., Sherman M., Brett-Smith H., ...More

41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Vienna, Austria, 26 - 30 April 2006, vol.44 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 44
  • Doi Number: 10.1016/s0168-8278(06)80081-4
  • City: Vienna
  • Country: Austria
  • Istanbul University Affiliated: No